E. Maubec

5.9k total citations · 1 hit paper
112 papers, 2.8k citations indexed

About

E. Maubec is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, E. Maubec has authored 112 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 36 papers in Dermatology and 32 papers in Epidemiology. Recurrent topics in E. Maubec's work include Cutaneous Melanoma Detection and Management (25 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Nonmelanoma Skin Cancer Studies (20 papers). E. Maubec is often cited by papers focused on Cutaneous Melanoma Detection and Management (25 papers), Cancer Immunotherapy and Biomarkers (21 papers) and Nonmelanoma Skin Cancer Studies (20 papers). E. Maubec collaborates with scholars based in France, United States and Canada. E. Maubec's co-authors include Marie‐Françoise Avril, Florent Grange, B. Crickx, Pierre Duvillard, Stéphane Dalle, Eduardo Marinho, Tony Petrella, M. Beylot‐Barry, Isabelle Scheer-Senyarich and Martine Bagot and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

E. Maubec

107 papers receiving 2.8k citations

Hit Papers

Phase II Study of Cetuximab As First-Line Single-Drug The... 2011 2026 2016 2021 2011 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Maubec France 29 1.4k 1.1k 978 569 465 112 2.8k
Priyadharsini Nagarajan United States 24 1.3k 0.9× 598 0.6× 551 0.6× 282 0.5× 390 0.8× 147 2.3k
Claudia Pföhler Germany 26 1.3k 0.9× 507 0.5× 247 0.3× 366 0.6× 497 1.1× 143 2.8k
George P. Lupton United States 29 879 0.6× 981 0.9× 595 0.6× 401 0.7× 88 0.2× 55 2.2k
Celia Requena Spain 30 1.8k 1.2× 1.4k 1.3× 870 0.9× 405 0.7× 292 0.6× 235 3.6k
Florent Grange France 35 1.9k 1.3× 2.0k 1.8× 1.8k 1.8× 1.4k 2.5× 534 1.1× 145 4.1k
Ralph J. Tuthill United States 29 1.3k 0.9× 429 0.4× 398 0.4× 441 0.8× 631 1.4× 84 2.7k
Wolfgang Weyers Germany 24 854 0.6× 529 0.5× 352 0.4× 324 0.6× 80 0.2× 87 1.7k
Catherine M. Stefanato United Kingdom 23 431 0.3× 1.4k 1.3× 672 0.7× 694 1.2× 353 0.8× 92 2.1k
Esperanza Jordá Spain 19 590 0.4× 442 0.4× 380 0.4× 253 0.4× 158 0.3× 127 1.5k
Hisashi Uhara Japan 32 2.1k 1.4× 894 0.8× 873 0.9× 261 0.5× 510 1.1× 158 3.2k

Countries citing papers authored by E. Maubec

Since Specialization
Citations

This map shows the geographic impact of E. Maubec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Maubec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Maubec more than expected).

Fields of papers citing papers by E. Maubec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Maubec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Maubec. The network helps show where E. Maubec may publish in the future.

Co-authorship network of co-authors of E. Maubec

This figure shows the co-authorship network connecting the top 25 collaborators of E. Maubec. A scholar is included among the top collaborators of E. Maubec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Maubec. E. Maubec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mortier, Laurent, Stéphane Dalle, O. Dereure, et al.. (2024). When to stop immunotherapy for advanced melanoma: Emulation of target trials.. Journal of Clinical Oncology. 42(16_suppl). 9521–9521.
4.
Baldini, Capucine, E. Maubec, Christine Longvert, et al.. (2023). Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients. Cancers. 15(17). 4330–4330. 3 indexed citations
5.
Gérard, E., Célèste Lebbé, Émilie Lanoy, et al.. (2023). 1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCA. Annals of Oncology. 34. S683–S683. 3 indexed citations
6.
Dalle, Stéphane, Laurent Mortier, S. Dalac, et al.. (2022). Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort. JCO Precision Oncology. 6(6). e2200075–e2200075. 6 indexed citations
7.
Dalac, S., Brigitte Dréno, Eve‐Marie Neidhardt, et al.. (2021). Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database. ESMO Open. 6(6). 100284–100284. 14 indexed citations
8.
Kervarrec, Thibault, Silke Appenzeller, M. Samimi, et al.. (2019). Polyomavirus-Positive Merkel Cell Carcinoma Derived from a Trichoblastoma Suggests an Epithelial Origin of this Merkel Cell Carcinoma. Journal of Investigative Dermatology. 140(5). 976–985. 28 indexed citations
9.
Brahimi, N., E. Maubec, Thomas Petit, B. Crickx, & V. Descamps. (2017). Pustulose exanthématique aiguë généralisée induite par le phloroglucinol (Spasfon®). Annales de Dermatologie et de Vénéréologie. 144(6-7). 423–425. 4 indexed citations
10.
Vaysse, Amaury, Shenying Fang, Myriam Brossard, et al.. (2016). A comprehensive genome‐wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants. International Journal of Cancer. 139(9). 2012–2020. 9 indexed citations
11.
Mellerio, Jemima E., Susan J. Robertson, Anja Diem, et al.. (2015). Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. British Journal of Dermatology. 174(1). 56–67. 87 indexed citations
12.
Messaoudene, Meriem, Giulia Fregni, J. Chanal, et al.. (2013). Mature Cytotoxic CD56bright/CD16 + Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma. Cancer Research. 74(1). 81–92. 79 indexed citations
13.
Maubec, E., Peter Petrow, Isabelle Scheer-Senyarich, et al.. (2011). Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin. Journal of Clinical Oncology. 29(25). 3419–3426. 334 indexed citations breakdown →
14.
Kérob, Delphine, Raphaël Porcher, O Vérola, et al.. (2010). Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients. Clinical Cancer Research. 16(12). 3288–3295. 98 indexed citations
15.
Hữu, Sáu Nguyễn, Michèle Oster, Marie‐Françoise Avril, et al.. (2009). Fetal Microchimeric Cells Participate in Tumour Angiogenesis in Melanomas Occurring during Pregnancy. American Journal Of Pathology. 174(2). 630–637. 59 indexed citations
16.
Brahimi, N., E. Maubec, O. Boccara, et al.. (2008). Pyoderma gangrenosum et abcès splénique aseptique. Annales de Dermatologie et de Vénéréologie. 136(1). 46–49. 11 indexed citations
17.
Meyer, Nicolás, et al.. (2007). Awareness, knowledge and attitudes towards sun protection among skin cancer‐treated patients in France. Journal of the European Academy of Dermatology and Venereology. 21(4). 520–525. 25 indexed citations
18.
Monsel, Gentiane, E. Maubec, C. Picard‐Dahan, et al.. (2007). Anévrysmes aortiques multiples au cours d’une polychondrite atrophiante. Annales de Dermatologie et de Vénéréologie. 134(6-7). 552–554. 4 indexed citations
19.
Grange, Florent, M. Beylot‐Barry, E. Maubec, et al.. (2007). Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type. Archives of Dermatology. 143(9). 1144–50. 144 indexed citations
20.
Maubec, E., Pierre Duvillard, Valérie Velasco, B. Crickx, & Marie‐Françoise Avril. (2005). Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin.. PubMed. 25(2B). 1205–10. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026